Abstract
The patenting of genetic material raises a host of concerns such as moral and ethical issues, the weakening of the utility requirement and the blockage of downstream research. This article examines the patentability of genetic material in the United States, Canada and the European Union. It discusses the advantages and disadvantages of the current patent system in relation to patents on genetic material. The article concludes with suggestions regarding the protection of intellectual property rights in light of growing concerns.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Recommended Citation
Adam Crane, "Of Mice and "Man": Patentability of Genetic Material and the Protection of Intellectual Property Rights" (2009) 18 Dal J Leg Stud 93.